SCHEMBL823101

SCHEMBL823101

OC1=CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28341409 0.90
SCHEMBL6536108 0.89
SCHEMBL6536110 0.89
SCHEMBL11725513 0.81
SCHEMBL11725502 0.81
SCHEMBL4410742 0.79
SCHEMBL22092417 0.79
SCHEMBL22092418 0.79
SCHEMBL5270720 0.79
SCHEMBL4410739 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117143340-A Preparation method and application of enol-terminated sulfhydryl compound 益丰新材料股份有限公司 2023-12-01 CN claimed
CN-104387405-A Method for synthesizing furo [3,2-c ] coumarin derivative UNIV CHANGSHA SCIENCE 2015-03-04 CN claimed
CN-119372242-A Construction method and application of VIGS silencing system for plant gene function identification 南京中医药大学 2025-01-28 CN disclosed
US-20240066010-A1 METHODS OF TREATING HEPATIC ENCEPHALOPATHY BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA) (PL) 2024-02-29 US disclosed
US-20240066010-A1 METHODS OF TREATING HEPATIC ENCEPHALOPATHY BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA) (PL) 2024-02-29 US disclosed
US-20240027902-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-01-25 US disclosed
CN-117177969-A Compound with benzyloxy aryl ether structure, preparation method and application thereof 中国科学院上海药物研究所 2023-12-05 CN disclosed
CN-117143340-A Preparation method and application of enol-terminated sulfhydryl compound 益丰新材料股份有限公司 2023-12-01 CN disclosed
WO-2023228661-A1 CHEMICAL-RESISTANT PROTECTIVE FILM 日産化学株式会社 2023-11-30 WO disclosed
WO-2023228662-A1 CHEMICAL-RESISTANT PROTECTIVE FILM 日産化学株式会社 2023-11-30 WO disclosed
EP-4276150-A1 ELECTRIC CONDUCTIVE POLYMER COMPOSITION Idemitsu Kosan Co., Ltd (JP) 2023-11-15 EP disclosed
US-20040073050-A1 Substituted cyclohexenes GIVAUDAN SA (CH) 2004-04-15 US disclosed
CN-1478064-A Substituted cyclohexenes ����µ��ɷ����޹�˾ 2004-02-25 CN disclosed
US-20030215801-A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method SIGMA-ALDRICH CO., LLC 2003-11-20 US disclosed
EP-1287404-A4 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD PROLIGO LLC (US) 2003-10-15 EP disclosed
EP-1339659-A1 SUBSTITUTED CYCLOHEXENES Givaudan SA (CH) 2003-09-03 EP disclosed
EP-1287404-A1 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD Proligo LLC (US) 2003-03-05 EP disclosed
WO-2002046131-A1 SUBSTITUTED CYCLOHEXENES GIVAUDAN SA (CH) 2002-06-13 WO disclosed
EP-1213276-A1 Substituted cyclohexenes Givaudan SA (CH) 2002-06-12 EP disclosed
WO-2001084234-A1 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD PROLIGO LLC (US) 2001-11-08 WO disclosed